Your browser doesn't support javascript.
loading
Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine.
Dashti, Navid; Golsaz-Shirazi, Forough; Soltanghoraee, Haleh; Zarnani, Amir-Hassan; Mohammadi, Mehdi; Imani, Danyal; Jeddi-Tehrani, Mahmood; Amiri, Mohammad Mehdi; Shokri, Fazel.
Affiliation
  • Dashti N; 1Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Golsaz-Shirazi F; 1Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Soltanghoraee H; 2Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
  • Zarnani AH; 1Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Mohammadi M; 3Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
  • Imani D; 4Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Jeddi-Tehrani M; 1Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Amiri MM; 5Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
  • Shokri F; 1Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Article in En | MEDLINE | ID: mdl-38753442

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Microbiol Immunol (Bp) Year: 2024 Document type: Article Affiliation country: Irán Country of publication: Hungria

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Microbiol Immunol (Bp) Year: 2024 Document type: Article Affiliation country: Irán Country of publication: Hungria